Stroke rates fall, but mortality rates vary by provinceStudy reveals benefits of organized care systems Aptiom for epilepsyNew “azepine” antiepileptic agent for partial-onset seizures in adults. Do benzodiazepines cause Alzheimer’s disease? Quebec study shows increased risk with cumulative exposure and longer-acting agents. Levodopa tops in Parkinson's Cannabis drugs helpful in MS, not in other neurological conditions But research review finds few studies of smoked marijuana Uric acid: Stroke treatment? Study opens ‘a completely fresh approach’ Vaccinations protect against childhood stroke Infections a preventable risk factor, study shows COPD bad for the brain Managing bacterial meningitis in children Updated statement outlines empiric antimicrobial therapy and clarifies the role of corticosteroids. Alemtuzumab for multiple sclerosis rejected by U.S. FDA Neurologists divided over the FDA’s decision. First Previous 37 38 39 40 41 Next Last
